Skip to main content

Bella Vi Insane Amp’d And Bella Vi Amp’d Up: Public Notification - Undeclared Ingredients

October 10, 2013

Audience: Consumer, Health Professional

[Posted 10/10/13]

ISSUE: FDA is advising consumers not to purchase or use Bella Vi Insane Amp’d or Bella Vi Amp’d Up. FDA laboratory analyses confirmed that Bella Vi Insane Amp’d and Bella Vi Amp’d Up contain sibutramine. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons.  These products pose a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and can present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.  These products can also interact in life-threatening ways with other medications a consumer may be taking. Laboratory analyses also confirmed that Bella Vi Insane Amp’d and Bella Vi Amp’d Up contain phenolphthalein. Phenolphthalein was an ingredient in some over-the-counter (OTC) laxative products until 1999 when FDA reclassified the ingredient as “not generally recognized as safe and effective.”

BACKGROUND: Bella Vi Insane Amp’d” and “Bella Vi Amp’d are promoted for weight loss and sold on various websites, as well as in retail stores.

RECOMMENDATION: Consumers should stop using these products immediately and throw them away.  Consumers who have experienced any negative side effects should consult a health care professional as soon as possible.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

[10/10/2013 - Public Notification - FDA]
[10/10/2013 - Tainted Weight Loss Products- FDA]

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.